COSM
Cosmos Health Inc.
$0.2100
+1.94%
$13.0M
No data for this timeframe.
Vol
Market Cap$13.0M
Cap SizeNano Cap
Inst. Holders15 funds
Inst. Value$413.8K
Inst. Activity1 buys / 0 sells
Reddit Sentiment71° Bullish
SEC Reports6
Press Releases8
Exchange Nasdaq·Sector Wholesale-Drugs, Proprietaries & Druggists' Sundries·Inc. NV·CIK 0001474167·Prev Close $0.2060
Recent Activity
Jun 12, 2026
SEC
Cosmos Health announced strong sales momentum for its proprietary antiseptic brands C-Scrub and C-Sept, with over $1.5 m
PRESS-RELEASE — Impact 4/10
Jun 8, 2026
SEC
Cosmos Health filed Amendment No. 1 to its S-3 shelf registration statement, primarily responding to SEC comments on ris
S-3/A — Impact 7/10
Jun 5, 2026
SEC
Cosmos Health filed a DEFA14A to correct a clerical error in the sample proxy card included with its June 2, 2026 defini
DEFA14A — Impact 2/10
Inst.
HRT FINANCIAL LP — DOUBLED
67,280 shares ($21.00)
Inst.
RENAISSANCE TECHNOLOGIES LLC — DOUBLED
334,575 shares ($166.6K)
Jun 12, 2026
Press
Cosmos Health's subsidiary Cana Laboratories received new contract manufacturing orders from Nassington and Verisfield f
Impact 3/10
Jun 12, 2026
contract
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Me
Jun 10, 2026
Press
Cosmos Health's subsidiary Cana Labs signed a three-year contract manufacturing deal with Verisfield to produce 1.3M uni
Impact 5/10
Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$4.50
Current $0.2100
Low $4.50
Median $4.50
High $4.50
1 analysts
$4.50
$4.50
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.01 ▲ +104.2% | $0.01 — $0.01 | 1 | |
| Next Q | $0.02 | $0.02 — $0.02 | 112% YoY | 1 |
| Current FY | $0.01 ▼ -87.5% | $0.01 — $0.01 | 102% YoY | 1 |
| Next FY | $0.07 | $0.07 — $0.07 | 600% YoY | 1 |
Latest Reports
NEUTRAL
Press
3/10
Cosmos Health's subsidiary Cana Laboratories received new contract manufacturing orders from Nassington and Verisfield f
Jun 12, 2026
NEUTRAL
PRESS-RELEASE
4/10
Cosmos Health announced strong sales momentum for its proprietary antiseptic brands C-Scrub and C-Sept, with over $1.5 m
Jun 12, 2026
BEARISH
S-3/A
7/10
Cosmos Health filed Amendment No. 1 to its S-3 shelf registration statement, primarily responding to SEC comments on ris
Jun 8, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| FMR LLC | — | — |
| RENAISSANCE TECHNOLOGIES LLC | $123.9K | DOUBLED |
| CITADEL ADVISORS LLC | $94.0K | DOUBLED |
| BlackRock, Inc. | $84.9K | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $44.4K | — |
Reddit Sentiment
71°
Bullish
Bearish
Neutral
Bullish
15 institutional holders with $413.8K total value (1,371,903 shares) as of 2026-Q1. Top holders: FMR, RENAISSANCE, CITADEL. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | FMR LLC | — | $0.00 | 0.0% | — |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 390,500 | $123.9K | 29.9% | DOUBLED +260.5% |
| 3 | CITADEL ADVISORS LLC | 296,300 | $94.0K | 22.7% | DOUBLED +133.1% |
| 4 | BlackRock, Inc. | 267,797 | $84.9K | 20.5% | — |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 140,007 | $44.4K | 10.7% | — |
| 6 | VANGUARD FIDUCIARY TRUST CO | 95,735 | $30.3K | 7.3% | — |
| 7 | STATE STREET CORP | 45,243 | $14.4K | 3.5% | ADD +82.9% |
| 8 | CITADEL ADVISORS LLC | 40,306 | $12.8K | 3.1% | DOUBLED +133.1% |
| 9 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 17,734 | $5.6K | 1.4% | — |
| 10 | NATIONAL BANK OF CANADA /FI/ | 6,357 | $2.0K | 0.5% | — |
| 11 | GROUP ONE TRADING LLC | 2,373 | $753.00 | 0.2% | TRIM -44.2% |
| 12 | Allworth Financial LP | 1,241 | $394.00 | 0.1% | — |
| 13 | CITIGROUP INC | 990 | $314.00 | 0.1% | — |
| 14 | HRT FINANCIAL LP | 67,280 | $21.00 | 0.0% | DOUBLED +162.2% |
| 15 | WELLS FARGO & COMPANY/MN | 40 | $13.00 | 0.0% | DOUBLED +900.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | DOUBLED | 25,661 | 67,280 | +162.2% | $21.00 | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 92,800 | 334,575 | +260.5% | $166.6K | 2025-Q4 |
| STATE STREET CORP | ADD | 24,743 | 45,243 | +82.9% | $22.5K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 4 | 40 | +900.0% | $20.00 | 2025-Q4 |
| HRT FINANCIAL LP | DOUBLED | 10,567 | 25,661 | +142.8% | $12.00 | 2025-Q4 |
| VANGUARD GROUP INC | ADD | 134,834 | 235,742 | +74.8% | $261.7K | 2025-Q3 |
| CITADEL ADVISORS LLC | DOUBLED | 96,731 | 225,507 | +133.1% | $250.3K | 2025-Q3 |
| GROUP ONE TRADING LLC | TRIM | 4,284 | 2,392 | -44.2% | $2.7K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 62,377 | 216 | -99.7% | $240.00 | 2025-Q3 |
| UBS Group AG | TRIM | 115,667 | 71,516 | -38.2% | $47.8K | 2024-Q4 |
| GROUP ONE TRADING LLC | ADD | 1,526 | 2,884 | +89.0% | $1.9K | 2024-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 131 | 173 | +32.1% | $116.00 | 2024-Q4 |
| GROUP ONE TRADING LLC | NEAR_EXIT | 9,881 | 1,526 | -84.6% | $1.3K | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 2 mixed, 2 neutral. Avg impact: 5.2/10.
NEUTRAL
PRESS-RELEASE
4/10
Cosmos Health announced strong sales momentum for its proprietary antiseptic brands C-Scrub and C-Se
Jun 12, 2026
BEARISH
S-3/A
7/10
Cosmos Health filed Amendment No. 1 to its S-3 shelf registration statement, primarily responding to
Jun 8, 2026
NEUTRAL
DEFA14A
2/10
Cosmos Health filed a DEFA14A to correct a clerical error in the sample proxy card included with its
Jun 5, 2026
MIXED
8-K
5/10
Cosmos Health reported Q1 2026 revenue of $17.93M, up 30.7% YoY, a new Q1 record, but GAAP net loss
May 22, 2026
BEARISH
S-3/A
7/10
Cosmos Health is registering 73.5 million shares for resale by two selling stockholders, ATW and M2B
Apr 24, 2026
MIXED
8-K
6/10
Cosmos Health reported full-year 2025 results with record revenue of $65.27M (up 20% YoY) and gross
Apr 16, 2026
NEUTRAL
3/10
Cosmos Health's subsidiary Cana Laboratories received new contract manufacturing orders from Nassing
Jun 12, 2026
BULLISH
5/10
Cosmos Health's subsidiary Cana Labs signed a three-year contract manufacturing deal with Verisfield
Jun 10, 2026
NEUTRAL
4/10
Cosmos Health subsidiary Cana Laboratories inaugurated a new capsule production line and secured a f
Jun 9, 2026
NEUTRAL
3/10
Cosmos Health's subsidiary Cana Laboratories acquired international patent application WO2025108566A
Jun 8, 2026
NEUTRAL
3/10
Cosmos Health announced the planned launch of its C-Scrub antimicrobial wash in a veterinary formula
Jun 1, 2026
NEUTRAL
4/10
Cosmos Health issued a multi-year financial guidance press release projecting revenue growth from $6
May 26, 2026
MIXED
6/10
Cosmos Health provided a corporate update highlighting record revenue, a U.S. expansion with its NOO
Mar 19, 2026
NEUTRAL
4/10
Cosmos Health Inc. (COSM) announced the purchase of $600,000 in Bitcoin, increasing its total digita
Mar 11, 2026
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$4.50 mean target
$4.50 Low
$4.50 High
| Metric | Value |
|---|---|
| Current Price | $0.2100 |
| Target Low | $4.50 |
| Target Mean | $4.50 |
| Target Median | $4.50 |
| Target High | $4.50 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.01 | $0.01 | $0.01 | — | +104.2% | 1↑ 0↓ | $0.0B | — | 1 |
| Next Q 2026-09-30 |
$0.02 | $0.02 | $0.02 | 111.8% | +0.0% | 1↑ 0↓ | $0.0B | — | 1 |
| Current FY 2026-12-31 |
$0.01 | $0.01 | $0.01 | 101.6% | -87.5% | 0↑ 1↓ | $0.1B | 33.8% | 1 |
| Next FY 2027-12-31 |
$0.07 | $0.07 | $0.07 | 600.0% | +0.0% | — | $0.1B | 26.9% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.010 | |
| 7d ago | $0.010 | |
| 30d ago | $-0.240 | +0.250 |
| 60d ago | $-0.030 | +0.040 |
| 90d ago | $-0.030 | +0.040 |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
71°
Bullish
Bearish
Neutral
Bullish
3 mentions
3 bullish
0 bearish
3 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 13, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Jun 13, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Feb 5, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
Roast my stock picks and tell me if you'd invest.
▲ 1
💬 1
⚡ 0.5
Jun 12, 2026
contract
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines
Jun 12, 2026
earnings
Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit
Cosmos Health announces strong sales momentum for its proprietary antiseptic brands, C-Scrub and C-Sept.
Jun 12, 2026
short_volume
Short Volume: COSM — 59.6% short (2.0M / 3.3M)
Short: 1,956,885 | Exempt: 345,062 | TRF Vol: 3,283,182 | Short Ratio: 59.6% | Off-exchange volume (dark pool + OTC)
Jun 11, 2026
m_and_a
Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio
Cosmos Health signs LOI to acquire Doc Pharma S.A.
Jun 11, 2026
activist
Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance
Cosmos Health secures additional 180-day Nasdaq extension to regain compliance.
Jun 11, 2026
short_volume
Short Volume: COSM — 55.8% short (1.4M / 2.4M)
Short: 1,355,496 | Exempt: 362,362 | TRF Vol: 2,429,878 | Short Ratio: 55.8% | Off-exchange volume (dark pool + OTC)
Jun 10, 2026
contract
Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries
Cosmos Health secures a 3-year contract manufacturing agreement for 3.9 million units of VASCLOR GEST progesterone pessaries.
Jun 10, 2026
short_volume
Short Volume: COSM — 60.0% short (2.5M / 4.1M)
Short: 2,479,853 | Exempt: 827,490 | TRF Vol: 4,135,292 | Short Ratio: 60.0% | Off-exchange volume (dark pool + OTC)
Jun 9, 2026
contract
Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN
Cosmos Health inaugurates state-of-the-art capsule production line and secures new 5-year contract manufacturing agreement for 385,000 units
Jun 9, 2026
short_volume
Short Volume: COSM — 57.5% short (2.1M / 3.7M)
Short: 2,122,276 | Exempt: 536,358 | TRF Vol: 3,693,852 | Short Ratio: 57.5% | Off-exchange volume (dark pool + OTC)
Jun 8, 2026
m_and_a
Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives
Cosmos Health acquires international patent application WO2025108566A1 and expands nanotechnology initiatives.
Jun 5, 2026
other
Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories
Cosmos Health launches Oliv18™, a USDA and EU certified whole olive polyphenol supplement targeting cardiovascular and antioxidant categories.
Jun 4, 2026
other
Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz
Sky Premium Life is now available for shipment across all 27 European Union Member States through Skroutz.
Jun 4, 2026
other
Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value
Cosmos Health identifies approximately $20 million in non-core assets available for monetization to accelerate growth and unlock shareholder value.
Jun 4, 2026
short_volume
Short Volume: COSM — 59.8% short (0.8M / 1.4M)
Short: 819,433 | Exempt: 145,175 | TRF Vol: 1,369,659 | Short Ratio: 59.8% | Off-exchange volume (dark pool + OTC)